- UroToday Home
- Urologic Oncology
Prostate Cancer Abstracts and Beyond
Recent Abstracts
-
MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer.Prostate CancerJanuary 20, 2022
-
Supportive care needs of men with prostate cancer: A systematic review update.Prostate CancerJanuary 20, 2022
-
Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.Prostate CancerJanuary 20, 2022
-
Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD.Prostate CancerJanuary 20, 2022
-
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8.Prostate CancerJanuary 20, 2022
-
Examination of prostate-specific antigen (PSA) screening in military and civilian men: analysis of the 2018 behavioral risk factor surveillance system.Prostate CancerJanuary 19, 2022
-
Value of T2 Mapping MRI for Prostate Cancer Detection and Classification.Prostate CancerJanuary 19, 2022
-
Diagnostic performance of fusion (US/MRI guided) prostate biopsy: propensity score matched comparison of elastic versus rigid fusion system.Prostate CancerJanuary 19, 2022
-
A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.Prostate CancerJanuary 19, 2022
-
Changes in Magnetic Resonance Imaging Radiomic Features in Response to Androgen Deprivation Therapy in Patients with Intermediate- and High-risk Prostate Cancer.Prostate CancerJanuary 19, 2022
Beyond the Abstracts
-
Live Cell Molecular Analysis of Primary Prostate Cancer Organoids Identifies Persistent Androgen Receptor Signaling - Beyond the AbstractProstate CancerJanuary 14, 2022
-
A High-Risk Decipher Biopsy Score is Associated with Conversion from Active Surveillance to Treatment and Treatment Failure in Localized Prostate Cancer - Beyond the AbstractProstate CancerJanuary 5, 2022
-
Health-Related Quality of Life in Men with Localized Prostate Cancer Treated with Radiotherapy: Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain - Beyond the AbstractProstate CancerJanuary 5, 2022
-
Detection Rate of 18F-Choline Positron Emission Tomography/Computed Tomography in Patients with Non-Metastatic Hormone Sensitive and Castrate Resistant Prostate Cancer - Beyond the AbstractProstate CancerJanuary 3, 2022
-
Prostate MRI Improves Diagnostic Performance of PSA for High Grade Prostate Cancer - Beyond the AbstractProstate CancerJanuary 3, 2022
-
A Comparative Study of Anticoagulant/Antiplatelet Therapy Among Men Undergoing Robot-Assisted Radical Prostatectomy: A Prospective Single Institution Study - Beyond the AbstractProstate CancerDecember 15, 2021
-
HIFU in Radio-Recurrent Localized Prostate Cancer - Beyond the AbstractProstate CancerDecember 14, 2021
-
Disparities in Germline Testing Among Racial Minorities with Prostate Cancer: Bridging Disparities in Germline Testing Among Men with Prostate Cancer - Beyond the AbstractProstate CancerDecember 7, 2021
-
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Beyond the AbstractProstate CancerDecember 6, 2021
-
Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis - Beyond the AbstractProstate CancerDecember 6, 2021
